Accrédit ation et d ' Evaluation en Sa nté, pp.1-10 ,
Genetic influences on lip id metabolism trait variability within the Stanislas Cohort, J Lip id Res, vol.1, issue.11, pp.42-1879 ,
The distribution of SNPs in human gene regulatory regions, BMC Genomics, issue.6, p.140, 2005. ,
A multilocus genotyping assay for candidate markers of cardiovascular disease risk, Genome Res, issue.9 10, pp.936-985, 1999. ,
A novel multilocus genotyp ing assay to identify genetic predictors ofstroke in sic/de cell anaemia, Br J Haematol, vol.1, issue.114 3, pp.718-738 ,
Gene interactions and stroke risk in chi/dren with sic/de cell anemia, Blood, vol.103, issue.9, pp.1-6, 2004. ,
APOC3, CETP, jibrinogen, and MTHFR are genetic determinants of carotid intima-media thickness in healthy men (the Stanislas cohort) ,
Analysis of the efJect of multiple genetic variants of cardiovascular disease risk on insulin concentration variability in healthy adults of the STANISLAS cohort. The role of FGB-455 GIA polymorphism, Atherosclerosis, vol.1, issue.2, pp.369-76, 2007. ,
Association between TNF and IL-I bloc polym orphisms and plasma MCP-I concentration. Atheroscle ros is, pp.348-53, 2007. ,
DOI : 10.1016/j.atherosclerosis.2006.05.015
A multilocus genotyping assay for cardiovasc ular disease, Clin Chem Lab Med, vol.8, issue.368, pp.56-57 ,
Cultures de cellules animales, Méthodologies -App lications. Techniques en, 2003. ,
Ap olip oprotein E genotype epsilon 4leps i/on 2 in the STANISLAS Cohort Study--domin ance of the eps ilon 2 alle, Ann Hum Genet, pp.60-509, 1996. ,
Control of ap olipoprotein E secretion in the human hep atoma cell line KYN-2, Cell Biochem Funct, vol.1, issue.191, pp.5-6 ,
The human leukemia cell line, THP-I : a multifacetted model for the study of monocyt e-macrophage difJerentiation. Experie ntia, pp.22-25, 1991. ,
EfJect of pitavastatin on apolipoprotein A-I production in HepG2 cell, Bio ch em Biophys Res Commun, vol.24, issue.32, pp.835-844, 2004. ,
Indu ction ofpro inflam matory cytokines and C-reactive protein in human macrophage cell line U937 exposed to air pollution particulates ,
Validation of in vitro cell models used in drug metabolism and transport studies; genotyp ing of cytochrome P450, phase II enzymes and drug transporter polym orphism s in the human hepatom a (HepG2 ,
Variations of the interleukin-6 promoter are associated with features of the metabolic syndrome in Caucasian Danes, Diabetologia, vol.52, issue.2, pp.251-60, 2005. ,
DOI : 10.1007/s00125-004-1623-0
Threonine for alanine substitution in the eotaxin (CCLI1) ge ne and the risk of incident myo cardial infarction. Atherosclero sis, pp.91-95, 2004. ,
Inflammation and Atherosclerosis: The Role of TNF and TNF Receptors Polymorphisms in Coronary Artery Disease, International Journal of Immunopathology and Pharmacology, vol.91, issue.1, pp.145-54, 2007. ,
DOI : 10.1136/bmj.316.7139.1236
Primary association of a TNF gene polymorphism with susceptibility to multiple sclerosis, Neurology, vol.53, issue.6, pp.1361-1364, 1999. ,
DOI : 10.1212/WNL.53.6.1361
Association between Gly 241Arg ICAM-I gene polymorphism and serum sICAM-I con centration in the Stanislas cohort Association of intercellular adh esion molecule-I gene with type 1 diab etes, Eur J Hum Genet Lancet, issue.9397, pp.36-38, 2003. ,
Assessme nt of the rol e ofge netic polymorphism in venous thrombosis through artificial neural networks, Ann Hum Genet, pp.69-693, 2005. ,
Endothelial NOS G894 T and MMP-3 5A/6A gene polymorphisms and hypertension in Serbian population, Journal of Clinical Laboratory Analysis, vol.13, issue.6, pp.241-247, 2005. ,
DOI : 10.1161/01.CIR.98.6.535
Genetic Polymorphisms in Cytokine and Adhesion Molecule Genes in Coronary Artery Disease, American Journal of PharmacoGenomics, vol.95, issue.18, pp.317-345, 2003. ,
DOI : 10.2165/00129785-200303050-00003
The E-selectin gene polymorphism and carotid atherosclerosis in end-stage renal disease, Nephrology Dialysis Transplantation, vol.21, issue.7, pp.1921-1927, 2006. ,
DOI : 10.1159/000081870
DNA polymorphisms in adh esion molecule ge nes--a new riskfactor for early ath erosclerosis, Hum Genet, vol.97, issue.1, pp.15-20, 1996. ,
Specifie P-selectin and Psselectin glycoprotein lig and-I genotypes/haplotypes are associated with risk ofincident CHD and ischemie stroke: The Atherosclerosis Risk in Communities (ARlC) study, Atherosclerosis, p.67, 2007. ,
Genetic control of the circulating concentration of transforming growth factor type beta1, Human Molecular Genetics, vol.8, issue.1, pp.93-100, 1999. ,
DOI : 10.1093/hmg/8.1.93
TGF-beta 1 polymorphisms and risk ofmyocardial infarction and stroke: the Rotterdam Study, Stroke, issue.11, pp.37-2667, 2006. ,
DOI : 10.1161/01.str.0000244779.30070.1a
URL : http://stroke.ahajournals.org/content/strokeaha/37/11/2667.full.pdf
Increased freq uency of the C3*F allele and the Leiden mutation of coag ulation factor V in patients with severe coronary heart dis eas e who survived myo cardial infarction, Exp Clin Immunogenet, vol.1, issue.184, pp.206-218 ,
Influ ence of the CD14 C260T promoter polymorphism on C-reactive protein levels in patients with coronary art ery dis ease ,
CD14 C (-260)T polymorphism, atherosclerosis, elderly: Role of cytokines and metallothioneins, International Journal of Cardiology, vol.120, issue.1, pp.45-51, 2006. ,
DOI : 10.1016/j.ijcard.2006.08.035
A CTLA-4 gene polymorphism at position ???318 in the promoter region affects the expression of protein, Genes & Immunity, vol.6, issue.4, pp.233-237, 2002. ,
DOI : 10.1046/j.1468-1331.1999.640491.x
Association of sixty-one non-synonymous polymorphisms in forty-one hypertension candidate ge nes with blood pressure variation and hypertension, Hyp ertens Res, issue.8, pp.29-611, 2006. ,
Associations between two common polymorphisms in the ABCA1 gene and subclinical atherosclerosis: Multi-Ethnic Study of Atherosclerosis (MESA), Atherosclerosis, vol.193, issue.2, pp.352-60, 2007. ,
DOI : 10.1016/j.atherosclerosis.2006.06.024
Common ge netic variation in the A TP-binding casse tte transporter A 1, plasma lip ids, and risk of coronary hear t disease ln-depth haplotype analysis of ABCA 1 ge ne polymorphisms in relation to plasma Ap oA l levels and myocardial infarction, Atherosclerosis, vol.24, issue.4, pp.775-81, 2004. ,
Polymorphisms in ABCG5 and AB CG8 transporters and p lasma cholesterol levels, Physiol Res, vol.53, issue.4, pp.395-435, 2004. ,
Cholesterol and saturated fat intake determine the effect of polymorphisms at ABCG5/ABCG8 genes on lipid levels in children, Genetics in Medicine, vol.40, issue.9, pp.594-603, 2006. ,
DOI : 10.1111/j.1651-2227.2002.tb00096.x
ABCB1 genotype and PGP expression, function and therapeutic drug response: a critical review and recommendations for future research, The Pharmacogenomics Journal, vol.14, issue.3, pp.154-79, 2007. ,
DOI : 10.1038/sj.ejhg.5201583
Multidrug resistance ge ne G1l99A polymorphism alters effl ux transport activity ofP-glycoprotein Pharmacogenetic scree ning of CYP3A and ABCB l in relation to population pharmacokinetics of docetaxel, J Pharmacol Exp Ther Clin Cancer Res, vol.10, issue.82, pp.1199-207, 2004. ,
gene are associated with the therapeutic response to risperidone in Chinese schizophrenia patients, Pharmacogenomics, vol.783, issue.7, pp.987-93, 2006. ,
DOI : 10.1023/A:1012244520615
Polymorphisms in human MDR1 (P-glycoprotein): recent advances and clinical relevance, Clinical Pharmacology & Therapeutics, vol.75, issue.1, pp.13-33, 2004. ,
DOI : 10.1016/j.clpt.2003.09.012
The APOA1/C3/A4/A5 gene cluster, lipid metabolism and cardiovascular disease risk, Current Opinion in Lipidology, vol.16, issue.2, pp.153-66, 2005. ,
DOI : 10.1097/01.mol.0000162320.54795.68
ApoC-IIl ge ne polymorphisms and risk of coronary artery disease, J Lipid Res, issue.9, pp.43-1450, 2002. ,
Association between ge netic varia tion at the APO AI-CIlI- AIV ge ne cluster and familial combined hyperlipidaemia, Clin Genet, issue.6, pp.46-385, 1994. ,
DOI : 10.1111/j.1399-0004.1994.tb04404.x
Uniqu e lip oprotein ph enotype and ge notype associated with excep tional longevity, Jama, issue.15, pp.290-2030, 2003. ,
Po lymorphisms in the CETP ge ne and association with CETP mass and HDL levels. Ath erosclerosis, pp.195-204, 2003. ,
Hepatic lipase mutations.elevated high -density lipoprotein cholesterol, and increased risk ofischemie heart disease: the Copenhage n City Heart Study, J Am Coll Cardiol, issue.11, pp.41-1972, 2003. ,
Hypertension ge nes are ge netic markers f or insulin sensitivity and resistan ce GLU-27 variant of beta 2-adrenergic receptor po lymorphisms is an independent risk factor for coronary ath erosclerotic disease Atheros clerosis, Hypertension, vol.45, issue.4, 2005. ,
164Jle al/ele in the beta2-Adrenergic receptor gene is associated with risk of elevated blood pressure in women. The Copenhagen City Heart Study, Pharmacogenet Genomics, issue.9, pp.15-633, 2005. ,
??2-Adrenergic receptor polymorphisms and treatment-induced regression of left ventricular hypertrophy in hypertension, Clinical Pharmacology & Therapeutics, vol.80, issue.6, pp.633-678, 2006. ,
DOI : 10.1016/j.clpt.2006.09.006
Is there a role of the Thr164Ile-??2-adrenoceptor polymorphism for the outcome of chronic heart failure?, Basic Research in Cardiology, vol.93, issue.6, pp.479-84, 2006. ,
DOI : 10.1152/ajpheart.00324.2003
Genetic variation in the renal sodium transporters NKCC2, NCC, and ENaC in relation to the efJects of loop diuretic drugs Linkage and association with the N OS2A locus on chromosome l 7qIl in multiple sclerosis, Clin Pharm acol Ther Ann Neurol, vol.82, issue.36, pp.55-79, 2004. ,
Promoter polymorphisms in the nitric oxide syn thase 3 gene are associated with ischemie stroke susceptibility in yo ung black women. Stro ke, pp.1848-51, 2005. ,
The glu298asp polymorphism in the nitric oxide synthase 3 gene is associated with the risk of ischemic stroke in two large independent case???control studies, Human Genetics, vol.13, issue.2, pp.169-78, 2007. ,
DOI : 10.1212/01.WNL.0000147542.37657.2F
Natriuretic peptide Val7Met substitution and risk of coronary artery disease in Greek patients with familial hypercholesterolemia, Journal of Clinical Laboratory Analysis, vol.5, issue.3, pp.98-104, 2006. ,
DOI : 10.1161/01.HYP.37.6.1416
Contribution of the -455G/A polymorphism at beta-fibrinogen gene and of the Leiden mutation to hemorh eological parameters in ischemie stro ke patients. Clin Hemorheo l Microe ire, pp.75-82, 2006. ,
Common ge netic variation in five thrombosis genes and relations to plasma hemostatic protein level and cardiovascular disease risk, Arterios cler Th romb Vase Biol, vol.26, issue.6, pp.140-145, 2006. ,
Genetic variation in coag ulation and fibrinolytic pro teins and their relation with acute myocardial infarction: a sys tematic review, Circulation, vol.1, issue.10425, pp.3063-3071 ,
Association ofPlasminog en Activator Inhibitor (PA!)-l (SERFINE1) SNPs with My oca rdial Infa rction , Plasm a PAl-l, and Metabolic Parameters. The HlFME CH Study, 2007. ,
A polymorphism in the TCF 7 gene, C883A, is assoc iated with type 1 diabetes. Di ab etes, pp.52-1579, 2003. ,
Association between a pro tein po ly morphism in the start codon of the vitamin D receptor ge ne and severe diabetic retinopathy in Cp eptide-negative type 1 diabetes, J Clin Endoerinol Metab, issue.8, pp.90-138, 2005. ,
Vitamin D'-binding pro tein g ene polymorphism association with IA-2 autoantibodies in type 1 diab etes, Clin Bio ehem, vol.38, issue.4, pp.15-24, 2005. ,
Consistent efJects ofgenes involved in reverse cholesterol transport on p lasma lipid and apo lipoprotein levels in CARDIA participants, Arterioscler Thro mb Vase Biol, issue.8, pp.26-1828, 2006. ,
Haplotyp es and SNPs in 13 lipid-relevant ge nes exp lain most of the genetic variance in high -density lipoprotein and low-density lipoprotein cholesterol, Hum Mol Genet, issue.10, pp.13-993, 2004. ,
Pharma cogenetic study of statin therapy and cholesterol reduction, Jama, vol.1, issue.1 2923, pp.282-283, 2004. ,
Pharmacogenomics of cholesterol-lowering therapy, Vascul Phannacol, vol.44, issue.2, pp.75-89, 2006. ,
An association study of 43 SNPs in 16 candidate genes with atorvastatin response, The Pharmacogenomics Journal, vol.75, issue.6, pp.352-360, 2005. ,
DOI : 10.1016/j.clpt.2003.12.016
The l'ole of common variants of ABCBl , CYP3A4, and CYP3A5 genes in lipi d-lowering efficacy and safety of simvastatin treatment, Clin Phannacol Th er, vol.5, issue.78 5, pp.55-56 ,
Adherence to and dosing of betahydroxy-beta-methylgluta ryl coenzyme A reductase inhibitors in the general population differs according to apolipoprotein E-gen0 types, Phannacogenetics, vol.13, issue.2, pp.19-23, 2003. ,
Arylamine N-acetyltransferase activity in human cultured celilines, Biochem J, issue.2, pp.294-342, 1993. ,
Transcobalamin codon 259 polymorphism in HT-29 and Caco-Z celis and in Caucasians: relation to transcobalamin and homocysteine concentration in blood, Blood, vol.1, issue.974, pp.1092-1100 ,
Study on the expression and mutation of human telomeric repeat binding fac tor (hTRF1) in 10 malignant hematopo ietic cell lines, J Zhejiang Univ Sei B, issue.612, pp.1141-1148, 2005. ,
The A4396G polymorphism in interferon regulatory factor 1 is frequently expressed in breast cancer cell lines, Cancer Genetics and Cytogenetics, vol.175, issue.1, pp.61-65, 2007. ,
DOI : 10.1016/j.cancergencyto.2006.12.008
Peroxisom e pro liferator-activated receptor gamma ligand-induced growth inhibition of human hepatoceliular carcinoma, Br J Cancer, vol.1, issue.841 2, pp.1640-1647 ,
Identification and expression of novel isoforms of human stromal cell-derived factor 1, Gene, vol.374, pp.174-183, 2006. ,
DOI : 10.1016/j.gene.2006.02.001
The stromal derived fa ctor-l mutated allele (SDF1-3'A) is associated with a lower incidence of atherosclerosis in HIV-inf ected pa tients, Aids, issue.16, pp.19-1877, 2005. ,
Clinical aspects of Clara cell I O-kDa prot ein/ uteroglobin (secretoglobin l AI). CUIT Phann Des, pp.1139-1188, 2003. ,
Accumulation of Dietary Cholesterol in Sitosterolemia Caused by Mutations in Adjacent ABC Transporters, Science, vol.290, issue.5497, pp.290-1771, 2000. ,
DOI : 10.1126/science.290.5497.1771
Pharmacokinetics and CYP2D6 genotypes do not predict metoprolol adverse events or efficacy in hyp ertension. Clin Phannacol Th er, pp.536-580, 2004. ,